| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,367,000 | 2,502,000 | 2,325,000 | 2,868,000 | | Cost of Revenue | 1,182,000 | 752,000 | 1,639,000 | 1,579,000 | | | Gross Profit | 1,185,000 | 1,750,000 | 686,000 | 1,289,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 860,000 | 1,280,000 | 273,000 | 839,000 | | Non Recurring |
-
|
-
|
-
| 1,535,000 | | Others | 166,000 | 166,000 | 178,000 | 178,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 159,000 | 304,000 | 235,000 | (1,263,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (433,000) | 512,000 | (262,000) | 445,000 | | Earnings Before Interest And Taxes | (31,000) | 882,000 | (93,000) | (2,007,000) | | Interest Expense | 194,000 | 161,000 | 154,000 | 176,000 | | Income Before Tax | (225,000) | 721,000 | (247,000) | (2,183,000) | | Income Tax Expense | (98,000) | 235,000 | (120,000) | (343,000) | | Minority Interest | (9,000) | (17,000) |
-
| (15,000) | | | | Net Income From Continuing Ops | 107,000 | 469,000 | (127,000) | (1,855,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (136,000) | 469,000 | (127,000) | (1,855,000) | | Preferred Stock And Other Adjustments |
-
| 9,000 | (9,000) |
-
| | | Net Income Applicable To Common Shares | ($136,000) | $478,000 | ($136,000) | ($1,855,000) |
|
1.52% Nasdaq 0.00%
Income Statement
